Automated SMS-Based Appointment Validation Tool
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01671189|
Recruitment Status : Unknown
Verified August 2012 by Medic Mobile.
Recruitment status was: Not yet recruiting
First Posted : August 23, 2012
Last Update Posted : August 23, 2012
|Condition or disease||Intervention/treatment||Phase|
|Diabetes Mellitus Type 2 Adult-onset Diabetes||Other: SMS Reminder Software Tool||Early Phase 1|
|Study Type :||Interventional (Clinical Trial)|
|Estimated Enrollment :||300 participants|
|Intervention Model:||Parallel Assignment|
|Masking:||None (Open Label)|
|Official Title:||An Automated SMS-Based Reminder and Rescheduling Tool to Improve Appointment Adherence Rates and Glycemic Control Among Diabetes Patients in San Mateo County|
|Study Start Date :||October 2012|
|Estimated Primary Completion Date :||October 2013|
|Estimated Study Completion Date :||December 2013|
Experimental: SMS Appointment Reminders
150 patients will be randomly assigned to the intervention arm of the study and receive text reminders about their upcoming appointments.
Other: SMS Reminder Software Tool
The 150 patients in the intervention arm of the study will receive SMS reminders regarding their upcoming appointments. Working in parallel with the SMMC electronic medical records system, the software tool will automate reminders that request text responses from patients to either confirm or request to reschedule their upcoming appointments. This bidirectional text messaging system would not interfere with the clinics' existing reminder protocol.
No Intervention: Existing Reminder Protocol
150 patients will be randomly assigned to the control arm of the study and will not receive SMS reminders about their upcoming appointments. They will, however, be subject to the clinics' existing reminder protocol (phone call reminders by either clinic personnel or computer machine).
- Glycemic Control (hemoglobin A1c) [ Time Frame: 6-9 months post-enrollment ]The hemoglobin A1c (HbA1c) levels of study participants will be measured at the time of enrollment and at the end of the 6-9 month follow-up period.
- Appointment Adherence Rate [ Time Frame: 6-9 month post-enrollment ]Appointments scheduled during the 6-9 month follow-up period will be systematically tracked and monitored. The proportion of fulfilled appointments will be compared between the intervention and control arms.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01671189
|Contact: Jessica Qufirstname.lastname@example.org|
|Contact: Mainul Islamemail@example.com|
|United States, California|
|San Mateo Medical Center||Not yet recruiting|
|San Mateo, California, United States, 94403|
|Contact: Mike Aratow, Dr. MAratow@smcgov.org|
|Contact: Jeanette Aviles, Dr. firstname.lastname@example.org|
|Principal Investigator:||Nadim Mahmud||Medic Mobile|